よむ、つかう、まなぶ。
資料２－２ WHO 推奨リスト (4 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/newpage_00058.html |
| 出典情報 | 厚生科学審議会 予防接種・ワクチン分科会 研究開発及び生産・流通部会 季節性インフルエンザワクチンの製造株について検討する小委員会（第8回 4／24）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
(9 World Health
NN Organization
Influenza B Victoria lineage egg-derived~ candidate vaccine viruses
for development and production of vaccinesfor use in the 2023-2024
northern hemisphere influenza season
占ntigEnIC and geEnetic analyses are herTarmed by the WHO Callaborating Centres nf the Glahal Influenza Surveillance arid
Reshonse Systerm |GISR5Sl. Unless ntherwise specified, 引 candidate vacririe Viruses hosted nn this tahle have hassed tWO-
way haemag加utinatian inhibition HI] test. Natianal or Reginnal control autharities approwe the composition and
formulation gf waccines used in each country=
25 February 2023
Candidate vaccine viruses [antigenically like B/Austria/1359417/2021 (egg
derived] - Accession number [GISAID): EPI_ISL 1519459
WHO CCs
MHRA, UK
VIDRL, 貞ustralia
BVR-26 Classjical SedIrU5 MHRAL UK
NIID, Japan
CDC, US放
BX-107作 Classical NYIMC MHRA, UK
NMYIMIC. US
CDC, US
B/IMichigan/01/021 Wild type virus MIHRA. UK
NIID, Japan
WHO CCs
MHRA, UK
WHO CCs
MHRA, UK
CNIC-2107A | Classical | CCDC,China WHO CCs
Wild type virus
B/Austria/1359417/2021
B/Singapore/WWUH4618/2021 Wild type virus
B/Guangdang- Wild type virus
〆henjiang1516必021
引用元 : WHOウェブサイト
https://www.who.int/teams/global-influenza-programme/vaccines/who-
recommendations/candidate-vaccine-viruseSs
NN Organization
Influenza B Victoria lineage egg-derived~ candidate vaccine viruses
for development and production of vaccinesfor use in the 2023-2024
northern hemisphere influenza season
占ntigEnIC and geEnetic analyses are herTarmed by the WHO Callaborating Centres nf the Glahal Influenza Surveillance arid
Reshonse Systerm |GISR5Sl. Unless ntherwise specified, 引 candidate vacririe Viruses hosted nn this tahle have hassed tWO-
way haemag加utinatian inhibition HI] test. Natianal or Reginnal control autharities approwe the composition and
formulation gf waccines used in each country=
25 February 2023
Candidate vaccine viruses [antigenically like B/Austria/1359417/2021 (egg
derived] - Accession number [GISAID): EPI_ISL 1519459
WHO CCs
MHRA, UK
VIDRL, 貞ustralia
BVR-26 Classjical SedIrU5 MHRAL UK
NIID, Japan
CDC, US放
BX-107作 Classical NYIMC MHRA, UK
NMYIMIC. US
CDC, US
B/IMichigan/01/021 Wild type virus MIHRA. UK
NIID, Japan
WHO CCs
MHRA, UK
WHO CCs
MHRA, UK
CNIC-2107A | Classical | CCDC,China WHO CCs
Wild type virus
B/Austria/1359417/2021
B/Singapore/WWUH4618/2021 Wild type virus
B/Guangdang- Wild type virus
〆henjiang1516必021
引用元 : WHOウェブサイト
https://www.who.int/teams/global-influenza-programme/vaccines/who-
recommendations/candidate-vaccine-viruseSs